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Abstract
Enhancing cholinergic function improves performance on various cognitive tasks and alters neural
responses in task specific brain regions. Previous findings by our group strongly suggested that the
changes in neural activity observed during increased cholinergic function may reflect an increase
in neural efficiency that leads to improved task performance. The current study was designed to
assess the effects of cholinergic enhancement on regional brain connectivity and BOLD signal
variability. Nine subjects participated in a double-blind, placebo-controlled crossover functional
magnetic resonance imaging (fMRI) study. Following an infusion of physostigmine (1mg/hr) or
placebo, echo-planar imaging (EPI) was conducted as participants performed a selective attention
task. During the task, two images comprised of superimposed pictures of faces and houses were
presented. Subjects were instructed periodically to shift their attention from one stimulus
component to the other and to perform a matching task using hand held response buttons. A
control condition included phase-scrambled images of superimposed faces and houses that were
presented in the same temporal and spatial manner as the attention task; participants were
instructed to perform a matching task.
Cholinergic enhancement improved performance during the selective attention task, with no
change during the control task. Functional connectivity analyses showed that the strength of
connectivity between ventral visual processing areas and task-related occipital, parietal and
prefrontal regions was reduced significantly during cholinergic enhancement, exclusively during
the selective attention task. Cholinergic enhancement also reduced BOLD signal temporal
variability relative to placebo throughout temporal and occipital visual processing areas, again
during the selective attention task only. Together with the observed behavioral improvement, the
decreases in connectivity strength throughout task-relevant regions and BOLD variability within
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stimulus processing regions provide further support to the hypothesis that cholinergic
augmentation results in enhanced neural efficiency.
Keywords
cholinergic system; neural efficiency; physostigmine; attention; functional magnetic resonance
imaging
1. Introduction
Selective attention constitutes the ability to discriminate relevant from irrelevant stimuli (i.e.
noise) and to process information within our environment preferentially (Desimone, 1998;
Desimone and Duncan, 1995; Kastner et al., 1998). The need for such a selective process
arises from a limited attentional capacity of the human brain, which produces a competition
for representation at a neural level when multiple stimuli are presented simultaneously
(Desimone, 1998; Kastner et al., 1998). The biased competition model of selective attention
(Desimone, 1998; Kastner et al., 1998) argues that the processing of stimuli within our
environment is based on an interaction between two mechanisms, ‘bottom-up’ processes that
act through stimulus-based operations, and ‘top-down’ processes that act through cognitive
or executive actions (Desimone, 1998; Duncan, 1998). Thus, the extent to which neural
processing is biased towards or away from any particular stimulus in the environment is
dependent on the resolution of interactions between these bottom-up and top-down attention
mechanisms.
While the cholinergic system is important in multiple cognitive domains, including memory
and attention, the literature suggests that the modulation of these functions may occur via
stimulus processing mechanisms (Bentley et al., 2011; Furey, 2011). At a behavioral level,
cholinergic modulation produced stimulus specific behavioral effects during attention tasks,
consistent with the modulation of the relative salience of competing visual stimuli (Bentley
et al., 2003a; Furey et al., 2008a). At a neuronal level, the direct application of acetylcholine
increased the selectivity of neural response to stimulus orientation in the cat visual cortex
(Sillito, 1986; Sillito and Kemp, 1983) consistent with enhancing signal, while cholinergic
input to the hippocampus is inhibitory, suggesting a modulation of S/N by reducing response
to noise (Buzsaki, 1989). Thus, modulation of S/N may constitute the neural mechanism
through which the cholinergic system may establish the relative strengths of stimulus
representations. At a regional level, functional brain imaging studies (Bentley et al., 2003a;
Freo et al., 2005; Furey et al., 2000c; Furey et al., 1997; Furey et al., 2008b; Ricciardi et al.,
2009) demonstrated that enhanced cholinergic activity selectively increased neural responses
to task relevant stimuli (i.e. signal) in visual processing cortical regions with reduced or no
change in neural responses to task-irrelevant stimuli (i.e. noise), consistent with the
hypothesized improvement of S/N ratio.
The enhanced representation of signal together with a reduced representation of noise
inherently is reflected in the interaction between top-down and bottom-up mechanisms
(Hasselmo et al., 1996; Sarter et al., 2001; Sarter et al., 2005; Sarter and Parikh, 2005), and
inherently results in shifting a processing bias among the competing stimuli. Functional
brain imaging studies have demonstrated that cholinergic enhancement selectively increases
neural activity in medial visual processing areas while reducing neural responses in lateral
visual extrastriate cortex (Bentley et al., 2003a, b; Furey et al., 2000c; Furey et al., 2008b;
Ricciardi et al., 2009) and in task-relevant prefrontal and parietal cortical regions (Bentley et
al., 2004; Bentley et al., 2003a, b; Freo et al., 2005; Furey et al., 2000c; Furey et al., 1997;
Furey et al., 2008b; Ricciardi et al., 2009). As these response modulations were
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accompanied by improved task performance, we hypothesized that these changes in brain
response are associated with an enhanced visual percept that rendered the task easier to
perform (Furey, 2011; Furey et al., 2000c). More specifically, the increased processing in
medial visual cortex may underlie a superior representation of the stimulus being processed,
which renders the task easier to perform and reduces the need to recruit prefrontal cortex.
Temporal variability in BOLD signal is thought to reflect cognitive capacity and integration
of information (Garrett et al., 2010, 2011), and changes in BOLD temporal variability
potentially could reflect shifts in S/N that reflect improvement in stimulus processing (Mohr
and Nagel, 2010; Samanez-Larkin et al., 2010). If the hypothesis that cholinergic
enhancement results in more efficient processing is correct, cholinergically mediated
decreases in task difficulty may manifest as changes in BOLD temporal variability within
task associated brain areas.
Changes in neural activity following cholinergic enhancement extend throughout task-
relevant brain regions (Bentley et al., 2004; Bentley et al., 2003a, b; Freo et al., 2005; Furey
et al., 2000c; Furey et al., 1997; Furey et al., 2008b; Ricciardi et al., 2009) and thus suggest
that the regional effects are likely not independent, but rather follow changes in
communication among task-important brain regions. Cholinergic activity reportedly affects
interactions among prefrontal, parietal and sensory brain regions (Golmayo et al., 2003;
Nelson et al., 2005), and some specifically have suggested that cholinergic transmission
influences anatomically segregated but functionally interconnected regional processes
(Bentley et al., 2011; Sarter et al., 2001). Thus our understanding of the neuromodulatory
effects of acetylcholine on efficiency of stimulus processing may benefit by investigating
changes in interregional connectivity.
Cholinergic potentiation-associated changes in neural activity that are identified based on
standard GLM approaches to data analysis are relatively subtle, and are described as simple
increases or decreases in neural activity associated with task related brain regions. We
anticipate that cholinergically mediated changes in neural response that reflect more
efficient processing can be characterized more effectively by using analysis procedures that
address both neural efficiency and regional interactions. Our previous findings have lead to
the hypothesis that increased cholinergic function produces enhanced visual percepts of
critical stimuli, and in this way results in a more efficient processing. In the current
manuscript, we explore this hypothesis by assessing functional efficiency as evaluated by
the strength of functional connectivity and by indices of BOLD temporal variability in task
relevant brain regions following cholinergic modulation.
2. Methods
2.1 Subjects
Nine healthy individuals (mean age±SD=31±6 years; four females/five males) participated
in a randomized, double-blind, placebo-controlled crossover study. All were right-handed,
normotensive, had no abnormalities on clinical examination or on laboratory tests (including
routine blood and urine tests, EKG, EEG, brain magnetic resonance imaging scan, and chest
X-ray), and no history of any relevant medical, neurological, or psychiatric disorder. All
were free of medication, including over-the-counter medications, for 4 weeks before the
study (Pietrini et al., 1996). All participants gave their written informed consent after the
purpose of the study and potential side effects of the drug had been fully explained. The
study was approved by the National Institute on Aging Institutional Review Board (NIH
protocol 00-M-0056).
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2.2.Experimental design
Subjects participated in two testing fMRI sessions, during which they received in random
order i.v. infusions of placebo and drug, and subsequently performed a selective attention
task. The physostigmine infusion schedule was as follows: a 10-minutes loading dose of
1.93 mg/h was used to quickly achieve the desired plasma levels followed by a maintenance
drip of 0.816 mg/h to maintain stable drug levels to completion of the study session, for a
total dose of 1.0 mg/hr. Infusions continued for 30 minutes prior to fMRI scanning to allow
drug effects to stabilize (Furey et al., 2000a; Furey et al., 2000c). Glycopyrrolate, a
cholinergic muscarinic antagonist that does not cross the blood-brain barrier, also was
administered (0.02 mg) to minimize peripheral side effects (Mirakhur et al., 1977; Oduro,
1975). Placebo infusions followed the same schedule while using saline. Blood pressure and
heart rate were monitored throughout each session for each subject.
2.3 Task design
Subjects performed a matching task while viewing two stimuli shown simultaneously, side
by side. In the selective attention task condition, two double-exposure pictures of faces and
houses were presented. Subjects were instructed by a cue to attend to either the face or the
house component of the stimuli, and to decide if the two exemplars from the attended
category were of the same person/house. Pictures with different views of the same person or
house were used so that subjects could not base their response on a simple pattern match.
Subjects were cued to shift their attention from one stimulus component to the other every
4–7 trials (Figure 1). Stimuli were presented for 2.5 s and were followed by a 1.5 s inter-trial
interval. In the control task, two stimuli were presented in the same spatial and temporal
manner but here the double-exposure images were phase scrambled to create stimuli that had
equivalent luminance, contrast, and spatial frequency spectra as the double-exposure
pictures. The control condition required subjects to determine if the scrambled images were
the same or different. To control for the presentation of the cue in the attention task, a cue
comprised of one large and one small ‘x’ (i.e., X x) was presented between the two
scrambled image stimuli. The cue changed every 4–7 trials by reversing the location of the
large and small x (e.g., x X), with no relevance to task requirements. Performance reaction
time and accuracy were recorded.
2.4 Image Acquisition and Experimental Task
Gradient echo, echo-planar (GRE-EPI) images were acquired with a 3 Tesla scanner
(General Electric, Milwaukee, WI). In each of 9 runs, 116 whole-brain volumes, comprised
of 40 contiguous, 3.5-mm, sagittal slices (field of view = 24 cm, echo time = 40 ms, flip
angle = 90, image in-plane resolution = 64×64 pixels), were obtained, resulting in a total of
1,044 volumes. High resolution T1-weighted spoiled gradient recall images were obtained
for each subject to provide detailed brain anatomy. MRI data were obtained at the National
Institutes of Health.
BOLD signal was measured as the selective attention task condition was performed over six
runs (the initial set of stimuli – faces or houses - was randomly alternated across runs), and
as the control task was performed over three runs. During the fMRI experiment, stimuli
were projected onto a rear-projection screen, and subjects responded using a hand-held
response button. Each run consisted of five blocks of stimuli for each type of target stimulus.
2.5 Behavioral data analysis
Mean reaction time (RT) was calculated across stimuli (faces and houses), and trials (trials
1–4) before group analyses. Mean RT as measured during placebo and during drug was
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compared using a t-test to determine overall drug effect. A more detailed report of the
behavioral data only has been published elsewhere (Furey et al., 2008a).
2.6 Functional data analysis
We used the AFNI and SUMA package and related software plugins to analyze and view
functional imaging data - http://afni.nimh.nih.gov/afni (Cox, 1996). The first four and the
last volumes from each run were discarded (resulting in a total of 999 volumes). All
volumes from across runs were concatenated and coregistered (3dvolreg), temporally
aligned (3dTshift), and spatially smoothed (isotropic Gaussian filter, s = 4 mm). One subject
was excluded from further analysis due to high level of head movement during scan
sessions.
Data were normalized by calculating the mean intensity value for each voxel, and then
dividing each time point within each voxel by its mean to estimate the percent signal
change. Individual voxel timeseries were transformed into the Talairach and Tournoux Atlas
(Talairach and Tournoux, 1988) coordinate system.
2.6.1. GLM analysis and ANOVA—Brain regions involved in the selective attention task
and in the control condition were identified using multiple regression (via 3dDeconvolve).
Regressors were created to model the attention shifts, and subsequent trials following each
shift. Regressors for the attention conditions (attention to faces and to houses) and for the
faces on scrambled and houses on scrambled control conditions were modeled separately;
for all conditions only the first 4 trials following a shift were included as regressors of
interest. The remaining trials (trials 5 through 7) were modeled as regressors of no interest
as these trials did not occur with every shift. The cues for both the selective attention and the
control task also were modeled. All regressors were convolved with a standard
hemodynamic response model. The six movement parameters derived from the volume
registration and the polynomial regressors to account for baseline shifts and linear/quadratic/
cubic drifts in each scan series were included in the model as regressors of no interest.
The mean functional response associated with the selective attention conditions was
obtained by averaging response measures across trials 1–4, and across the attention to faces
and to houses conditions. This resulted in an average response to the selective attention task,
without separating across trial or attention conditions.
A three-way mixed model ANOVA (task: selective attention vs. control condition; drug:
physostigmine vs. placebo; subjects as random a variable) was conducting using
unthresholded β-weights of each condition. BOLD estimates for task conditions were based
on an inherent, resting baseline condition. T-contrasts were calculated to identify significant
differences between task conditions (selective attention vs. control condition) and between
infusion conditions (physostigmine vs. placebo). An ANOVA was p< 0.05 conducted to test
for a task × drug interaction. Voxelwise significance of p< 0.05 was used, and a whole brain
correction was applied using 3dClustSim in AFNI to control for multiple comparisons to
result in a corrected p< 0.05, and requires a minimum cluster volume of 837 µL.
2.6.2. ROI-based functional connectivity analysis—For the functional connectivity
analysis, two procedures were used to identify regions of interest (ROIs) based on peak task-
dependent activity (selective attention and the control tasks were combined; voxel-wise
p<0.05, uncorrected) as measured separately during the saline and physostigmine conditions
(thus producing ‘placebo ROIs’ and ‘drug ROIs’, respectively). The following analyses were
conducted separately on each of the two sets of ROIs.
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Infusion conditions were considered separately for two reasons. First, in our previous
functional brain studies of cholinergic modulation, we reported drug-induced, task-related
increases and decreases in brain activity (e.g. Freo et al., 2005; Furey et al., 2000c; Furey et
al., 1997; Furey et al., 2008b; Ricciardi et al., 2009). Selecting ROIs from the saline infusion
condition only could, therefore, potentially exclude regions that selectively responded to
drug in some manner. Second, the selection of representative ROIs is a critical step in
functional connectivity analyses. When different methods of ROI selection have been
compared, quantitatively different results have been reported (Marrelec and Fransson, 2011;
Poldrack, 2007). In our study, we employed different ROI selection procedures to rule out
the possibility that our findings might be due merely to a bias in ROI selection. The results
obtained using ROIs as defined by the drug activity maps are provided as Supplementary
material only.
Preprocessed data (as defined in 2.6) were low-pass filtered (3dFourier) at 0.15 Hz to
remove high frequency physiological artifacts including cardiac and respiratory pulsatility,
with no effects on the features of BOLD signal change related to the task (Birn et al., 2006).
The influence of the six motion correction parameters derived from the volume registration
and the polynomial regressors that account for baseline shifts and linear/quadratic/cubic
drifts in each scan series were mathematically removed from the voxel timeseries
(3dSynthesize) (Lund et al., 2006).
We identified ROI peaks by combining structural and functional information. For each of
the infusion conditions separately, the task-related activity maps were superimposed onto
the anatomical regions of a probabilistic cytoarchitectonic atlas (Eickhoff et al., 2005). Any
potential ROI was required to have an arbitrary minimum volume of 200 µL to limit the
number of anatomical regions included in the analysis (Marrelec and Fransson, 2011;
Poldrack, 2007). A 4 mm radius sphere was placed onto the positive activity peak of each
ROI (see Figure S2). The average BOLD signal was extracted for each ROI separately for
the selective attention and control conditions, under placebo and physostigmine. Pearson’s r
correlation coefficients were calculated among ROIs, to derive four correlation matrices for
each subject. To test the strength of each functional connection at an individual level, each r
coefficient within each correlation matrix was tested against 500 surrogates generated by
randomizing the Fourier phases of the original signal (Theiler, 1992) using the TISEAN
software package (Hegger et al., 1999; Schreiber and Schmitz, 2000). The surrogates had the
same power spectrum and autocorrelation function as the original timeseries to test the null
hypothesis that the correlations between ROIs depend on linearly filtered Gaussian noise
(Hlinka et al., 2011). A one sided rank-order test was performed to obtain a p-value
associated with the original Pearson’s r correlation coefficient. The correlation p-values for
each ROI were combined across subjects using Fisher’s combined probability test (Fisher,
1925). Only those correlations retaining significance in the group analysis using a False
Discovery Rate (FDR) correction (p < 0.05) were included in subsequent analyses
(Benjamini and Yekutieli, 2001).
To conduct group analyses, correlation coefficients for each subject were transformed into Z
scores using Fisher’s Z transformation, and paired two-sample two-tailed t-tests were
performed between drug and task conditions (p<0.05). We then compared the number of the
observed significant correlations at p<0.05 with the number of significant correlations to be
expected using a Poisson distribution as the model. All functional connectivity coefficients
were positive as the selected ROIs resulted from t-tests against baseline.
2.6.3. Voxel-wise functional connectivity analysis on representative regions—
Given the effects on neural activity in prefrontal and extrastriate visual areas following
cholinergic modulation (Bentley et al., 2003a, b; Furey et al., 2000c; Furey et al., 2008a;
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Ricciardi et al., 2009), two representative regions were selected from the placebo ROIs, one
in ventro-temporal and another in prefrontal cortex, and used as ‘seeds’ to perform a whole
brain functional connectivity analysis (3dfim+). In brief, average BOLD signal of each
selected ROI was calculated for the selective attention condition under both placebo and
physostigmine, and was correlated with each individual voxel timeseries across the brain.
Individual correlation coefficient maps were transformed into Z score maps using Fisher’s Z
transformation, and a paired two-sample two-tailed t-test was performed between the two
infusion conditions to identify brain areas showing drug-associated differences in
connectivity strength (p<0.05, whole brain corrected).
While the previous ROI-based functional connectivity analysis described drug-related
changes in specific ROIs distributed throughout the brain, this voxelwise approach
incorporates whole brain information regarding changes in functional connectivity.
Furthermore, the behavior of two representative prefrontal and extrastriate visual areas,
implicated in the cholinergic enhancement of attention processes, has been specifically
characterized.
2.6.4. Temporal brain variability analysis—Temporal brain variability was measured
using the mean squared successive difference (MSSD) as calculated on individual voxel
timeseries using the preprocessed data that was used for the functional connectivity analysis
(e.g. concatenated and coregistered, temporally aligned, spatially smoothed and normalized
volumes for each task type, as described in Section 2.6). We applied an additional
preprocessing step by regressing out white matter (WM) and cerebrospinal fluid (CSF)
timeseries (Garrett et al., 2010; Samanez-Larkin et al., 2010). WM and CSF time courses
were extracted from two small (1 voxel radius) ROIs located in the corpus callosum and
lateral ventricle, respectively, and were identified on a common template, which was
obtained by merging spatially normalized anatomical images of all subjects. Temporal
BOLD signal variability measures were calculated on the whole brain volume, within-
subject, for each task type, thus concatenating selective attention task runs and control
condition runs, separately. Paired t contrasts were used to compare the MSSD indices
between task (selective attention vs. control condition) and drug (physostigmine vs. placebo)
conditions, and to determine the task × drug interaction. The correction for multiple
comparisons was made using Monte-Carlo simulations run via 3dClustSim in AFNI with a
voxelwise threshold of p < 0.05, whole brain corrected to p< 0.05.
All statistical results were anatomically localized on Talairach-transformed T1-weighted
images, and visualized using normalized SUMA surface templates.
3. Results
3.1 Behavioral findings
Mean reaction time while performing the selective attention task was significantly faster
during the physostigmine as compared to placebo condition (mean RT ± S.D.:
physostigmine = 1755 ± 259 s, placebo: 1819 ± 257 s; p= 0.027). No drug-related RT
changes occurred during the control task (mean RT ± S.D.: physostigmine = 1284 ± 275 s,
placebo: 1267 ± 242 s; p> 0.3). For a detailed report of the behavioral results see Furey et
al., 2008a.
3.2 Drug -related BOLD response during the selective attention and control tasks
During placebo and physostigmine, significant (p<0.05 whole brain corrected) increases in
BOLD during the selective attention task as compared to a rest baseline were observed
bilaterally in occipital and temporal visual extrastriate regions - extending into fusiform,
Ricciardi et al. Page 7
Neuropharmacology. Author manuscript; available in PMC 2014 January 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
lingual and parahippocampal giri - superior parietal and intraparietal regions, premotor
(BA6), middle prefrontal (BA9) and anterior insula/inferior prefrontal areas. Additional
activations were found in left sensorimotor and inferior parietal cortex and bilateral
thalamus. Selective attention task-related decreases were found in default-mode regions,
including bilateral medial frontal areas, precuneus, supramarginal and inferior parietal
cortex, posterior portion of superior temporal gyrus, and temporal poles (Figures 2A and
2B). Significant drug-associated differences were observed only in early visual cortical areas
where activity decreased during cholinergic enhancement as compared to saline infusion
(Figure 2C).
During the control condition, a similar task-related pattern in occipital and temporal visual
extrastriate regions, superior parietal and intraparietal areas was observed (Figures 2D and
E). An additional bilateral recruitment of the sensorimotor region was seen. Similarly,
cholinergic enhancement induced significant decreases only in early visual areas (Figure
2F).
During placebo, the selective attention task produced larger increases in BOLD than the
sensorimotor control task in bilateral middle occipital and fusiform cortex, and a larger
reduction in BOLD in right inferior parietal/supramarginal cortex (Figure 2G). During
physostigmine, the selective attention task produced larger increases in BOLD response in
bilateral ventral and dorsal extrastriate regions, intraparietal and superior parietal cortex, and
in right middle frontal cortex, and the control task produced larger BOLD increases in the
right sensorimotor cortex (Figure 2H). During cholinergic enhancement, larger decreases in
BOLD were seen bilaterally in inferior parietal/supramarginal cortex and postcentral cortex
during the selective attention task as compared to the control task.
No cluster survived whole brain correction in the task × drug interaction.
3.3 Functional connectivity
The superimposition of the task-related activity maps with the anatomical regions of a
probabilistic cytoarchitectonic atlas (Eickhoff et al., 2005) resulted in 42 ROIs for the
placebo condition and 42 ROIs for the physostigmine condition.
3.3.1 Placebo ROIs—In a task comparison during placebo, the functional connectivity
strength of striate and extrastriate visual cortical regions was significantly greater during the
selective attention task than the control task within the ventral and dorsal temporal and
occipital visual areas, including fusiform and lingual cortex, as well as bilateral inferior
parietal and precentral cortical areas, and inferior and middle frontal regions (Figure 3A).
During physostigmine, functional connectivity strength within occipital visual regions
diminished during the selective attention task, but the same occipital areas maintained
significantly higher correlations with ventrotemporal extrastriate visual areas, including
fusiform and parahippocampal areas, and with inferior frontal areas (Figure 3B).
Additionally, ventrotemporal regions showed no difference in connectivity strength with
prefrontal and parietal regions between the two experimental conditions, as was seen during
placebo. Indeed, during cholinergic enhancement, the functional connectivity strength of
visual occipital ROIs with sensorimotor and precentral areas was higher during the control
condition than during the selective attention task. In both task contrasts, the number of
observed correlations corresponded to a p<0.00001 when compared to the expected number
of correlations based on the Poisson distribution.
The drug comparison during the attention selective task confirmed significant diffuse
reductions in functional connectivity during cholinergic enhancement as compared to
placebo (p<0.00001 when compared to the expected number of correlations based on the
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Poisson distribution), primarily among ventrotemporal, occipital and prefrontal ROIs
(Figure 3C). The drug comparison during the control condition showed no major change in
functional connectivity, and the number of observed significant differences was lower than
expected from the Poisson distribution (Figure 3D).
3.3.2 Drug ROIs—When estimating the strength of the functional connectivity in task-
related brain regions identified during cholinergic enhancement, the results of task and drug
comparisons overlapped considerably with results provided above (3.3.1). Nonetheless, the
results are provided in supplemental material for completeness (Figure S2).
3.3.3 Voxel-vise analysis—In Figure 4, functional connectivity maps for the two
representative ROIs, located in the left middle frontal and in the right fusiform cortex, are
shown to supplement the previous results (reported in section 3.3.1). Consistently, during
selective attention the functional connectivity strength was significantly reduced during
physostigmine (relative to placebo) between the right fusiform seed and the fronto-parietal
regions (p<0.05, whole brain correction). Similarly, the left middle frontal seed showed
reduced functional connectivity with bilateral prefrontal regions and with dorsal and ventral
extrastriate clusters following cholinergic enhancement.
3.4 Temporal variability
The task contrast during placebo showed a higher BOLD temporal variability during the
selective attention task as compared to the control condition in bilateral ventro-temporal, and
occipito-temporal and dorsal occipital extrastriate regions (p< 0.05, whole brain corrected)
(Figure 5A). An additional cluster of higher BOLD temporal variability was located in the
left inferior frontal cortex (Figure 5A). During cholinergic enhancement, higher temporal
variability in ventral extrastriate regions during the selective attention task was limited to a
right medial temporal/fusiform cluster (Figure 5B) (p< 0.05, whole brain corrected),
consistent with drug-associated reductions in functional connectivity strength reported above
(sections 3.3.1 and 3.3.2). Additionally, during physostigmine administration, significantly
higher MSSD during the control condition was found bilaterally in the posterior cingulate/
precuneus and calcarine cortex (Figure 5A).
Drug contrasts showed a significant drug-associated decrease in MSSD in bilateral early
visual regions and lingual cortex, and in right ventral extrastriate cortex during
physostigmine administration (Figure 5C). No significant drug-related change was found in
the control condition (Figure 5D).
4. Discussion
The results of the current study support the hypothesis that enhanced cholinergic function
may lead to a more efficient stimulus processing, which renders tasks less demanding.
Exclusively during the selective attention task, and not during the control condition,
cholinergic modulation induced by physostigmine reduced both the strength of connections
and the BOLD temporal variability in task-related areas, particularly implicating visual
processing extrastriate regions. Cholinergic enhancement also improved performance
exclusively during the selective attention task, again with no change during the control task.
Specifically, the results of the functional connectivity analysis showed that cholinergic
enhancement reduces the strength of connections between the visual processing regions and
task-related occipital, parietal and prefrontal regions. The absence of effects during the
control task indicates that the changes in connectivity are related specifically to conditions
that retain multiple stimuli and thus compete for neural processing resources. Of note, the
drug-associated reductions in connectivity strength made the pattern of connectivity under
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cholinergic enhancement to become more sparse, and thus more specific, among ventral
temporal and occipital loci during the selective attention task, and among frontal, parietal
and visual occipital regions during the control task (please refer to Figures 3A and 3B).
Importantly, the connections between prefrontal and parietal regions with visual processing
areas were reduced during the selective attention task as compared to the placebo condition.
Moreover, the results of the seed-based correlation analysis are consistent with the ROI-
based connectivity analysis, lending further support to these findings.
These specific task-related reductions in the strength of connectivity between stimulus
processing visual extrastriate areas and prefrontal and parietal regions may be related
directly to previous work showing that cholinergic enhancement improves behavioral
performance on visual tasks while reducing neural responses in frontoparietal regions
(Bentley et al., 2004; Bentley et al., 2003a, b; Freo et al., 2005; Furey et al., 2000c; Furey et
al., 1997; Furey et al., 2008b; Ricciardi et al., 2009). We hypothesized that cholinergic
potentiation may enhance the efficiency of perceptual processing, and thereby produce an
enhanced visual percept of task-relevant stimuli. The improved percept accordingly
decreases the effort required to perform the task, and indirectly diminishes the need to
allocate attentional resources (Furey, 2011). Consistent with this hypothesis, studies that
investigated functional correlates of learning and expertise observed that increased
automaticity and improved performance are reflected in both reduced recruitment of
attention regions and a downscaling of connectivity strength between these attention regions
and task-related sensory areas (Rypma et al., 2006; Toni et al., 2002). Furthermore, studies
evaluating the influence of cognitive load on connectivity suggest that, as task difficulty
decreases, the strength of connections among task-relevant regions also decreases (Fu et al.,
2006). Consequently, the reduced strength in functional connectivity between visual
processing regions and frontal and parietal areas, together with the observed behavioral
improvement, may reflect both a more efficient processing of task-significant stimuli and a
reduction in the effort required to perform the task (Neubauer and Fink, 2009; Rypma and
Prabhakaran, 2009).
We also observed extensive cholinergically mediated change in BOLD temporal variability
throughout ventral temporal, occipital and parietal cortices. Under placebo, a higher BOLD
variability was observed broadly in the lateral extents of visual processing areas during the
selective attention as compared to the control task condition. Cholinergic enhancement
resulted in a widespread decrease in BOLD variability specifically during the selective
attention task, so that BOLD variability differences were virtually absent in lateral visual
processing extrastriate areas, and medial occipital areas showed significantly less BOLD
variability during the selective attention task versus the control condition. Thus, the
influence of cholinergic enhancement on BOLD temporal variability is limited to the
selective attention condition only, and does not exert any specific influence during the
control condition.
Indices of BOLD signal temporal variability are associated with information processing and
integration mechanisms, which relate directly to neural efficiency (Garrett et al., 2010, 2011,
2012b; Mohr and Nagel, 2010; Samanez-Larkin et al., 2010; Leo et al., in press). While the
meaning of these physiological fluctuations in BOLD signal remains empirical, a decrease in
variability also has been related to reductions in connectivity (Garrett et al., 2012b; Misic et
al., 2011; Vakorin et al., 2011). In our study, the lateral visual processing areas showed a
higher variability during the attention task (vs. control) under placebo, but showed no
variability difference under cholinergic enhancement. Importantly, these lateral visual
processing regions overlap with the ventro-temporal extrastriate ROIs that showed reduced
functional connectivity with prefrontal and parietal regions. Therefore, the reductions in
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MSSD indices are observed in the same regions showing changes in functional connectivity
strength between visual processing regions and prefrontal and parietal areas.
Recently, decreases in signal variability have been related specifically to both a reduction of
long-range functional connections and thus to a reduction in the extent of distributed
networks (Vakorin et al., 2011). These decreases in variability were interpreted as a
reflection of more homogeneous inputs resulting in more local processing of information
(Misic et al., 2011). Two main consequences may be derived from this. First, the decreases
in BOLD signal variability during cholinergic potentiation may reflect a less distributed and
less connected network subserving selective attention processes. This less distributed
network also is reflected in the more sparse pattern of connectivity under physostigmine,
observed among ventral temporal and occipital loci during selective attention. Second, as the
reductions in signal variability are mainly located in ventral extrastriate areas, these may
also reflect both a reduction in noise and thus an enhanced signal (Garrett et al., 2010, 2011,
2012b; Mohr and Nagel, 2010; Samanez-Larkin et al., 2010). As physostigmine enhances
the cholinergically-mediated effects on S/N processing (Furey, 2011; Furey et al., 2000c),
the presence of less variable dynamics should lead to an increased homogeneity of sensory
representations in visual extrastriate regions (Garrett et al., 2012b; Misic et al., 2011;
Vakorin et al., 2011).
Finally, as a greater brain signal variability often reflects improved and more stable
cognitive performance (Garrett et al., 2010, 2011, 2012b), the prediction would be that
improved behavioral performance following cholinergic enhancement would be
accompanied by an increased BOLD signal variability. Although, recent fMRI data during a
face matching task in healthy young participants (Garrett et al., 2012a) confirmed a positive
linear relation between signal variability and task performance, this relation was evident
only at a certain degree of task difficulty. No differences as compared to the control
condition were found in those conditions that did not reach that given difficulty threshold,
and resulted simpler to perform. In our study, during physostigmine infusion signal
variability in visual processing regions did not differ between the selective attention and the
control task, consistent with the hypothesis that cholinergic enhancement may lead to a more
efficient stimulus processing that renders the selective attention task less demanding. Indeed,
differences between the task and control conditions in visual processing regions were found
selectively during placebo.
In the current study, the neuromodulatory effects of cholinergic enhancement were
associated with pervasive changes in interregional connectivity and BOLD variability, rather
than with small localized regional changes in neural responses. The standard GLM analysis
presented here showed higher levels of activity in visual extrastriate and frontoparietal
regions during the selective attention task as compared to the control condition, consistent
with previous studies (Haxby et al., 1994; Kastner et al., 1998). Drug effects were observed
exclusively in early visual areas, in which neural activity decreased aspecifically during
cholinergic enhancement.
Previously, we and others have reported both increases and decreases in neural activity
following cholinergic enhancement in visual processing areas, as reflected also by both
changes in the extent of cortex that responds to task and in the magnitude of the neural
response (Bentley et al., 2004; Freo et al., 2005; Furey et al., 2000b; Furey et al., 2000c;
Furey et al., 1997; Furey et al., 2008b; Ricciardi et al., 2009). Decreases in response were
non-selective for task condition, and thus reflected a more aspecific effect of cholinergic
enhancement. Increases in BOLD response in visual cortex were stimulus dependent, and
thus were not merely an aspecific effect of the drug. As the current study was not designed
to evaluate stimulus specific (only task specific) drug effects, stimulus specific increases in
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BOLD response would not have been detected. Thus, the absence of BOLD increases in
visual cortex likely is a reflection of the specific analysis conducted here, which was
designed to suit the purposes of the current study.
In summary, several findings in the literature indicate that the effects of cholinergic
potentiation on task performance may be due to enhanced processing of task relevant
stimuli, as reflected by specific changes in the magnitude of the BOLD response. In the
current paper, we used functional connectivity and estimates of BOLD signal variability to
evaluate neural efficiency, and the results suggest that increasing cholinergic function leads
to more efficient neural responses. These effects are observed in task-relevant stimulus
processing regions specifically during the selective attention task, with no such changes
evident during the control task.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Highlights
– Physostigmine improves performance and alters brain response to cognitive
tasks
– We evaluated cholinergic effects on neural efficiency during selective
attention
– Physostigmine reduced connectivity and BOLD variability of visual areas
during task
– Cholinergic enhancement improves task-specific neural efficiency
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Figure 1.
The selective attention and control tasks.
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Figure 2.
Brain regions showing increased (red) and decreased (blue) BOLD response during
performance of the selective attention task (A–B–C) and the control task (D–E–F) relative to
a crosshair baseline condition are shown. Panels A–D and panels B–E show results as
measured during placebo and physostigmine respectively. Panels G and H show the
interaction between the selective attention and controls tasks under each infusion condition;
panels C and F show the interaction between infusion conditions for each task condition
separately. T-score maps are projected onto a standard Talairach template which includes
lateral views and a top view, results are thresholded at a whole brain corrected significance
level of p < 0.05.
Ricciardi et al. Page 18
Neuropharmacology. Author manuscript; available in PMC 2014 January 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Ricciardi et al. Page 19
Neuropharmacology. Author manuscript; available in PMC 2014 January 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 3.
Forty-two ROIs that were recruited to perform the selective attention and control tasks were
identified under placebo. Connectivity matrices are shown to identify all correlations among
the 42 ROIs that differ significantly between the selective attention and control task
conditions under placebo (A) and physostigmine (B), correlations that are larger during
selective attention are shown in red and correlation that are larger during the control task are
shown in green. Connectivity matrices also are shown to identify significant differences in
connectivity strength between placebo and physostigmine during the selective attention task
(C) and the control task (D) with correlations that are larger during placebo shown in green
and correlations that are larger during physostigmine shown in red. SelAttn= Selective
Attention; Phy= Physostigmine condition; Pla= Placebo condition.
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Figure 4.
Functional connectivity maps of two representative ROIs, located in right fusiform cortex
(A) and the left middle frontal cortex (B) are shown. Brain areas showing larger correlations
with the seed ROI (identified by the red spheres) during placebo (blue) and physostigmine
(red) are presented. T-score maps are projected onto a standard Talairach template which
includes lateral and medial views of both hemispheres; results are thresholded at a whole
brain corrected significance level of p < 0.05.
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Figure 5.
Significant differences in BOLD signal variability between the selective attention and
control tasks are shown for the placebo (A) and physostigmine (B) conditions; regions with
higher BOLD variability are indicated in red-yellow for the selective attention task and blue
for the control task. Differences in BOLD signal variability between the placebo and
physostigmine conditions also are shown for the selective attention task (C) and the control
task (D). T-score maps are projected onto a standard talairach template including a lateral
view and three representative axial slices; results are thersholded at a whole brain corrected
significance level of p < 0.05. SelAttn= Selective Attention; Phy= Physostigmine condition;
Pla= Placebo condition.
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